The Food and Drug Administration and the Centers for Disease Control and Protection said in a joint statement that the suspension was "out of an abundance of caution" after six women who received the J&J shot were diagnosed with blood clots.
The Food and Drug Administration and the Centers for Disease Control and Protection said in a joint statement that the suspension was "out of an abundance of caution" after six women who received the J&J shot were diagnosed with blood clots.